Peptide lipidation stabilizes structure to enhance biological function
Open accessAbstract
Medicines that decrease body weight and restore nutrient tolerance could improve human diabetes and obesity treatment outcomes. We developed lipid-acylated glucagon analogs that are co-agonists for the glucagon and glucagon-like peptide 1 receptors, and stimulate weight loss and plasma glucose lowering in pre-diabetic obese mice. Our studies identified lipid acylation (lipidation) can increase and balance in vitro potencies of select glucagon analogs for the two aforementioned receptors in a lipidation site-dependent manner. A general capacity for lipidation to enhance the secondary structure of glucagon analogs was recognized, and the energetics of this effect quantified. The molecular structure of a lipid-acylated glucagon analog in water was also characterized. These results support that lipidation can modify biological activity through thermodynamically-favorable intramolecular interactions which stabilize structure. This establishes use of lipidation to achieve specific pharmacology and implicates similar endogenous post-translational modifications as physiological tools capable of refining biological action in means previously underappreciated.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The chemical nature of the acylation influences not only the pharmacokinetics of the peptide but also the pharmacophore itself, and such modifications are not inert bystanders with respect to biological activity and biodistribution.
“Importantly, this demonstrates that the chemical nature of the acylation influences not only the pharmacokinetics of the peptide but also the pharmacophore itself, which further highlights that such modifications are not inert bystanders with respect to biological activity [48] and biodistribution [49].”
From Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice (2022) · cites this paper as [48]
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,994 · see citing works
NMR with Proteins and Nucleic Acids
Wüthrich, K. (1986) · Europhysics news · doi:10.1051/epn/19861701011 · Cited by 8,025 · see citing works
NMR of Proteins and Nucleic Acids
(2006) · Royal Society of Chemistry eBooks · doi:10.1039/9781847555236-00336 · Cited by 5,863 · see citing works
Using circular dichroism spectra to estimate protein secondary structure
Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.202 · Cited by 4,031 · see citing works
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
Fields, G., & NOBLE, R. L. (1990) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,490 · see citing works
The Xplor-NIH NMR molecular structure determination package
Schwieters, C. D., Kuszewski, J. J., Tjandra, N., & Clore, G. M. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(02)00014-9 · Cited by 2,371 · see citing works
Ulrich, E. L., Akutsu, H., Doreleijers, J. F., Harano, Y., Ioannidis, Y., Lin, J. C., Livny, M., Mading, S., Maziuk, D., Miller, Z., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm957 · Cited by 1,472 · see citing works
Molecular and Cellular Endocrinology
Rainey, W. E., & Rodgers, R. J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.10.007 · Cited by 1,309 · see citing works
Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.204 · Cited by 886 · see citing works
Knudsen, L. B., Nielsen, P. F., Huusfeldt, P. O., Johansen, N. L., Madsen, K., Pedersen, F. Z., Thøgersen, H., Wilken, M., & Agersø, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9909645 · Cited by 705 · see citing works
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641 · see citing works
Self-citationPrinciples of physical biochemistry
Holde, K. E. V., Johnson, W. C., & Ho, P. S. (1998) · Cited by 580 · see citing works
Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation
Kang, R., Wan, J., Arstikaitis, P., Takahashi, H., Huang, K., Bailey, A. O., Thompson, J. X., Roth, A. F., Drisdel, R. C., Mastro, R., et al. (2008) · Nature · doi:10.1038/nature07605 · Cited by 533 · see citing works
Large-scale profiling of protein palmitoylation in mammalian cells
Martin, B. R., & Cravatt, B. F. (2009) · Nature Methods · doi:10.1038/nmeth.1293 · Cited by 511 · see citing works
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin
Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 431 · see citing works
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409 · see citing works
Protein palmitoylation and subcellular trafficking
Aicart-Ramos, C., Valero, R. A., & Rodríguez‐Crespo, I. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.009 · Cited by 373 · see citing works
Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation
Lin, D.-T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., & Huganir, R. L. (2009) · Nature Neuroscience · doi:10.1038/nn.2351 · Cited by 347 · see citing works
Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonance
Braun, W. A., Wider, G., Lee, K. H., & Kurt Wüthrich, A. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80143-0 · Cited by 340 · see citing works
Structure-activity studies of glucagon-like peptide-1.
Adelhorst, K., Hedegaard, B. B., Knudsen, L. B., & Kirk, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37366-0 · Cited by 283 · see citing works
Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273 · see citing works
Evaluation of a Quantitative Magnetic Resonance Method for Mouse Whole Body Composition Analysis
Tinsley, F. C., Taicher, G. Z., & Heiman, M. L. (2004) · Obesity Research · doi:10.1038/oby.2004.20 · Cited by 244 · see citing works
Madsen, K., Knudsen, L. B., Agersoe, H., Nielsen, P. F., Thøgersen, H., Wilken, M., & Johansen, N. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070861j · Cited by 244 · see citing works
Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
Parthier, C., Reedtz‐Runge, S., Rudolph, R., & Stubbs, M. T. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.02.004 · Cited by 193 · see citing works
Dynamic structure of membrane-anchored Arf•GTP
Liu, Y., Kahn, R., & Prestegard, J. H. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1853 · Cited by 139 · see citing works
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
Russell-Jones, D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.018 · Cited by 137 · see citing works
Day, J. W., Gelfanov, V., Smiley, D., Carrington, P. E., Eiermann, G., Chicchi, G., Erion, M. D., Gidda, J., Thornberry, N. A., Tschöp, M. H., et al. (2012) · Peptide Science · doi:10.1002/bip.22072 · Cited by 133 · see citing works
Self-citationEffect of Phosphorylation on α-Helix Stability as a Function of Position
Andrew, C. D., Warwicker, J., Jones, G. R., & Doig, A. J. (2002) · Biochemistry · doi:10.1021/bi0113216 · Cited by 133 · see citing works
Reiersen, H., & Rees, A. R. (2000) · Protein Engineering Design and Selection · doi:10.1093/protein/13.11.739 · Cited by 119 · see citing works
Moffett, S., Adam, L., Bonin, H., Loisel, T. P., Bouvier, M., & Mouillac, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21490 · Cited by 114 · see citing works
[1] Concept and early development of solid-phase peptide synthesis
Merrifield, R. B. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)89040-4 · Cited by 106 · see citing works
Thornton, K. H., & Gorenstein, D. G. (1994) · Biochemistry · doi:10.1021/bi00178a009 · Cited by 102 · see citing works
Charych, E. I., Jiang, L.-X., Lo, F., Sullivan, K., & Brandon, N. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1635-10.2010 · Cited by 98 · see citing works
Johansson, J., Nilsson, G., Strömberg, R., Robertson, B., Jörnvall, H., & Curstedt, T. (1995) · Biochemical Journal · doi:10.1042/bj3070535 · Cited by 93 · see citing works
Phosphorylation destabilizes α-helices
Szilák, L., Moitra, J., Krylov, D. Y., & Vinson, C. (1997) · Nature Structural Biology · doi:10.1038/nsb0297-112 · Cited by 84 · see citing works
Multiple-site replacement analogs of glucagon. A molecular basis for antagonist design.
Unson, C. G., Wu, C. R., Fitzpatrick, K., & Merrifield, R. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99910-2 · Cited by 45 · see citing works
Farnesylation of the SNARE Protein Ykt6 Increases Its Stability and Helical Folding
Pylypenko, O., Schönichen, A., Ludwig, D., Ungermann, C., Goody, R. S., Rak, A., & Geyer, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.099 · Cited by 43 · see citing works
Krstenansky, J. L., Trivedi, D. B., & Hruby, V. J. (1986) · Biochemistry · doi:10.1021/bi00361a014 · Cited by 39 · see citing works
Alaña, I., Malthouse, J. P. G., O'Harte, F. P. M., & Hewage, C. M. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21372 · Cited by 35 · see citing works
Site-specific Effects of Peptide Lipidation on β-Amyloid Aggregation and Cytotoxicity
Qahwash, I. M., Boire, A. A., Lanning, J. D., Krausz, T. N., Pytel, P., & Meredith, S. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702146200 · Cited by 22 · see citing works
Unson, C. G., Wu, C.-R., Cheung, C. P., & Merrifield, R. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10308 · Cited by 22 · see citing works
Patterson, J. T., Day, J. W., Gelfanov, V. M., & DiMarchi, R. D. (2011) · Journal of Peptide Science · doi:10.1002/psc.1385 · Cited by 16 · see citing works
Self-citationStabilization of conformationally dynamic helices by covalently attached acyl chains
Poschner, B. C., & Langosch, D. (2009) · Protein Science · doi:10.1002/pro.155 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645 · see citing works
Self-citationFactors affecting the physical stability (aggregation) of peptide therapeutics
Zapadka, K. L., Becher, F. J., dos Santos, A. L. G., & Jackson, S. (2017) · Interface Focus · doi:10.1098/rsfs.2017.0030 · Cited by 404 · see citing works
Prebiotic Peptides: Molecular Hubs in the Origin of Life
Frenkel-Pinter, M., Samanta, M., Ashkenasy, G., & Leman, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00664 · Cited by 354 · see citing works
Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
Erak, M., Bellmann‐Sickert, K., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.012 · Cited by 327 · see citing works
Antimicrobial peptides: an alternative for innovative medicines?
da Costa, J. P., Cova, M. M., Ferreira, R. M., & Vitorino, R. M. P. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6375-x · Cited by 206 · see citing works
Salameh, T. S., Rhea, E. M., Talbot, K., & Banks, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114187 · Cited by 188 · see citing works
Impact of processing on the chemistry and functionality of food proteins
Aryee, A. N. A., Agyei, D., & Udenigwe, C. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100722-8.00003-6 · Cited by 187 · see citing works
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
Capozzi, M. E., DiMarchi, R. D., Tschöp, M. H., Finan, B., & Campbell, J. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00117 · Cited by 153 · see citing works
Self-citationNext generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Knerr, P. J., Mowery, S. A., Douros, J. D., Premdjee, B., Hjøllund, K. R., He, Y., Kruse Hansen, A. M., Olsen, A. K., Perez-Tilve, D., DiMarchi, R. D., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101533 · Cited by 147 · see citing works
Self-citationDerivatization with fatty acids in peptide and protein drug discovery
Kurtzhals, P., Østergaard, S., Nishimura, E., & Kjeldsen, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00529-w · Cited by 137 · see citing works
D’Aloisio, V., Dognini, P., Hutcheon, G. A., & Coxon, C. R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.019 · Cited by 125 · see citing works
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
Evers, A., Haack, T., Lorenz, M., Bossart, M., Elvert, R., Henkel, B., Stengelin, S., Kurz, M., Glien, M., Dudda, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00174 · Cited by 101 · see citing works
Peptide Lipidation – A Synthetic Strategy to Afford Peptide Based Therapeutics
Kowalczyk, R., Harris, P. W. R., Williams, G. M., Yang, S., & Brimble, M. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66095-0_9 · Cited by 101 · see citing works
Transformation of Oligomers of Lipidated Peptide Induced by Change in pH
Wang, Y., Lomakin, A., Kanai, S., Alex, R., & Benedek, G. B. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500519s · Cited by 86 · see citing works
Photo-induced radical thiol–ene chemistry: a versatile toolbox for peptide-based drug design
Ahangarpour, M., Kavianinia, I., Harris, P. W. R., & Brimble, M. A. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00354a · Cited by 84 · see citing works
Protein and Peptide Biopharmaceuticals: An Overview
Agyei, D., Ahmed, I., Akram, Z., Iqbal, H. M. N., & Danquah, M. K. (2017) · Protein and Peptide Letters · doi:10.2174/0929866523666161222150444 · Cited by 83 · see citing works
Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery
Yang, P., Zou, H., Chao, E., Sherwood, L., Núñez, V., Keeney, M., Ghartey-Tagoe, E. B., Ding, Z., Quirino, H., Luo, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601653113 · Cited by 69 · see citing works
Yang, P., Zou, H., Lee, C., Muppidi, A., Chao, E., Fu, Q., Luo, X., Wang, D., Schultz, P. G., & Shen, W. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00768 · Cited by 68 · see citing works
Recent advances in the design of antimicrobial peptide conjugates
Silva, A. R. P., Guimarães, M. D. S., Rabelo, J., Belén, L. H., Perecin, C. J., Farías, J. G., Santos, J. H. P. M., & Rangel‐Yagui, C. D. O. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02757c · Cited by 66 · see citing works
Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”
Apostol, C. R., Hay, M., & Polt, R. L. (2020) · Peptides · doi:10.1016/j.peptides.2020.170369 · Cited by 54 · see citing works
Antimicrobial peptides used as growth promoters in livestock production
Rodrigues, G. R., Maximiano, M. R., & Franco, O. L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11540-3 · Cited by 50 · see citing works
Evers, A., Bossart, M., Pfeiffer‐Marek, S., Elvert, R., Schreuder, H., Kurz, M. E., Stengelin, S., Lorenz, M., Herling, A. W., Konkar, A. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00292 · Cited by 50 · see citing works
Knerr, P. J., Mowery, S. A., Finan, B., Perez-Tilve, D., Tschöp, M. H., & DiMarchi, R. D. (2020) · Peptides · doi:10.1016/j.peptides.2019.170225 · Cited by 49 · see citing works
Self-citationGenetically Encoded Cholesterol-Modified Polypeptides
Mozhdehi, D., Luginbuhl, K. M., Dzuricky, M. J., Costa, S. A., Xiong, S., Huang, F. C., Lewis, M. M., Zelenetz, S. R., Colby, C. D., & Chilkoti, A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10687 · Cited by 49 · see citing works
Design of potent and proteolytically stable oxyntomodulin analogs
Muppidi, A., Zou, H., Yang, P. Y., Chao, E., Sherwood, L., Nunez, V., Woods, A. K., Schultz, P. G., Lin, Q., & Shen, W. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00787 · Cited by 44 · see citing works
Faya, M. A., Hazzah, H. A., Omolo, C. A., Agrawal, N., Maji, R., Walvekar, P., Mocktar, C., Nkambule, B. B., Rambharose, S., Alberício, F., et al. (2020) · Amino Acids · doi:10.1007/s00726-020-02903-7 · Cited by 46 · see citing works
Ramos-Álvarez, I., Mantey, S. A., Nakamura, T., Nuche‐Berenguer, B., Moreno, P., Moody, T. W., Maderdrut, J. L., Coy, D. H., & Jensen, R. T. (2015) · Peptides · doi:10.1016/j.peptides.2015.01.009 · Cited by 44 · see citing works
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Puszkarska, A. M., Taddese, B., Revell, J. D., Davies, G., Field, J., Hornigold, D. C., Buchanan, A. G., Vaughan, T. J., & Colwell, L. J. (2024) · Nature Chemistry · doi:10.1038/s41557-024-01532-x · Cited by 43 · see citing works
Wang, Y., Lomakin, A., Kanai, S., Alex, R., Belli, S., Donzelli, M., & Benedek, G. B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.035 · Cited by 43 · see citing works
King, K., Lin, N.-P., Cheng, R. Y.-H., Chen, G.-H., & Chein, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.672097 · Cited by 41 · see citing works
Small cyclic agonists of iron regulatory hormone hepcidin
Chua, K. J., Fung, E., Micewicz, E. D., Ganz, T., Nemeth, E., & Ruchala, P. P. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.03.012 · Cited by 39 · see citing works
Isono, A., Tsuji, M., Sanada, Y., Matsushita, A., Masunaga, S., Hirayama, T., & Nagasawa, H. (2019) · ChemMedChem · doi:10.1002/cmdc.201800793 · Cited by 39 · see citing works
Alavi, S. E., Cabot, P. J., Raza, A., & Moyle, P. M. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00091 · Cited by 37 · see citing works
Lipidization as a tool toward peptide therapeutics
Myšková, A., Sýkora, D., Kuneš, J., & Maletı́nská, L. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2284685 · Cited by 36 · see citing works
Hutchinson, J. A., Hamley, I. W., Torras, J., Alemán, C., Seitsonen, J. J. T., & Ruokolainen, J. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b11097 · Cited by 36 · see citing works
Solid‐Phase Thiol–Ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist
Williams, E. T., Harris, P. W. R., Jamaluddin, A., Loomes, K. M., Hay, D. L., & Brimble, M. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805208 · Cited by 35 · see citing works
Antimicrobial Peptides Controlling Resistant Bacteria in Animal Production
Rodrigues, G. R., dos Santos, L. S., & Franco, O. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.874153 · Cited by 35 · see citing works
Mäde, V., Bellmann‐Sickert, K., Kaiser, A., Meiler, J., & Beck‐Sickinger, A. G. (2014) · ChemMedChem · doi:10.1002/cmdc.201402235 · Cited by 31 · see citing works
Atangcho, L., Navaratna, T. A., & Thurber, G. M. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.008 · Cited by 31 · see citing works
Liu, K., Yang, L., Peng, X., Wang, J., Lu, J. R., & Xu, H. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b03774 · Cited by 31 · see citing works
Korczek, K. R., Tkaczewska, J., Duda, I., & Migdał, W. (2019) · Journal of Aquatic Food Product Technology · doi:10.1080/10498850.2019.1695033 · Cited by 30 · see citing works
Singh, R. S., Mishra, N. K., Singh, N., Rawal, P., Gupta, P., & Joshi, K. B. (2020) · New Journal of Chemistry · doi:10.1039/d0nj01501f · Cited by 30 · see citing works
Mallart, S., Ingenito, R., Bianchi, E., Bresciani, A., Esposito, S., Gallo, M., Magotti, P., Monteagudo, E., Orsatti, L., Roversi, D., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01533 · Cited by 29 · see citing works
Lynch, A. M., Pathak, N., Flatt, Y. E., Gault, V. A., O'Harte, F. P. M., Irwin, N., & Flatt, P. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.018 · Cited by 27 · see citing works
Zhang, L., Navaratna, T. A., & Thurber, G. M. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00209 · Cited by 26 · see citing works
Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability
Schönauer, R. A.-R., Els‐Heindl, S., Fischer, J., Köbberling, J., Riedl, B., & Beck‐Sickinger, A. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00126 · Cited by 25 · see citing works
Optimization of peptide-based polyagonists for treatment of diabetes and obesity
Knerr, P. J., Finan, B., Gelfanov, V. M., Pérez–Tilve, D., Tschöp, M. H., & DiMarchi, R. D. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.10.047 · Cited by 23 · see citing works
Self-citationMikulášková, B., Zemenová, J., Pirník, Z., Pražienková, V., Bednářová, L., Železná, B., Maletı́nská, L., & Kuneš, J. (2015) · Peptides · doi:10.1016/j.peptides.2015.11.005 · Cited by 23 · see citing works
Pickford, P., Lucey, M., Rujan, R., McGlone, E. R., Bitsi, S., Ashford, F. B., Junior, I. R. C., Hodson, D. J., Tomás, A., Deganutti, G., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101242 · Cited by 20 · see citing works
Kostelnik, K. B., Els‐Heindl, S., Klöting, N., Baumann, S., von Bergen�, M., & Beck‐Sickinger, A. G. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.008 · Cited by 20 · see citing works
Innovative chemical synthesis and conformational hints on the lipopeptide liraglutide
Guryanov, I., Bondesan, A., Visentini, D., Orlandin, A., Biondi, B., Toniolo, C., Formaggio, F., Ricci, A., Zanon, J., & Cabri, W. (2016) · Journal of Peptide Science · doi:10.1002/psc.2890 · Cited by 20 · see citing works
Figueira, T. N., Mendonça, D. A., Gaspar, D., Melo, M. N., Moscona, A., Porotto, M., Castanho, M. A. R. B., & Veiga, A. S. (2018) · ACS Nano · doi:10.1021/acsnano.8b01422 · Cited by 19 · see citing works
Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists
Jiang, N., Jing, L., Li, Q., Su, S.-B., Yang, Q., Zhou, F. L., Chen, X., Han, J. D. J., Tang, C., & Tang, W. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113118 · Cited by 19 · see citing works
Lāce, I., Cotroneo, E. R., Hesselbarth, N., & Simeth, N. A. (2022) · Journal of Peptide Science · doi:10.1002/psc.3466 · Cited by 17 · see citing works
Zhihong, Y., Chen, W., Qianqian, Z., Lidan, S., Zhou, Q., Han, J. D. J., Wenxi, W., & Bhawal, R. P. (2023) · Peptides · doi:10.1016/j.peptides.2023.170955 · Cited by 17 · see citing works
The Structural Refinement of Glucagon for Therapeutic Use.
Chabenne, J. R., Mroz, P., Mayer, J., & DiMarchi, R. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01493 · Cited by 14 · see citing works
Self-citationDauer, K., Kamm, W., Wagner, K. G., & Pfeiffer‐Marek, S. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01028 · Cited by 16 · see citing works
Peptides for biopharmaceutical applications
Agyei, D., Tan, K. X., Pan, S., Udenigwe, C. C., & Danquah, M. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100736-5.00009-0 · Cited by 16 · see citing works
Solid‐Phase Thiol–Ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist
Williams, E. T., Harris, P. W. R., Jamaluddin, A., Loomes, K. M., Hay, D. L., & Brimble, M. A. (2018) · Angewandte Chemie · doi:10.1002/ange.201805208 · Cited by 14 · see citing works
Prolonging parathyroid hormone analog action in vitro and in vivo through peptide lipidation
Höppner, J., Noda, H., Anitha, A. K., Cheloha, R. W., Dean, T., Bruce, M., Brooks, D. J., Mannstadt, M., Bouxsein, M., Gellman, S. H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59665-7 · Cited by 13 · see citing works
Development of Peptide Biopharmaceuticals in Russia
Deigin, V. I., Poluektova, E. A., Герович, Б. А., Kozin, S. A., & Poluektov, Y. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040716 · Cited by 13 · see citing works
Wang, X., Zhang, R., Lindaman, B. D., Leeper, C. N., Schrum, A. G., & Ulery, B. D. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00981 · Cited by 12 · see citing works
Palani, A., Nawrocki, A. R., Orvieto, F., Bianchi, E., Mandić, E., Pessi, A., Huang, C., Deng, Q., Toussaint, N., Walsh, E., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00217 · Cited by 11 · see citing works
Design, structure of amphiphilic peptide and its application from single molecule to nanoparticle
Wang, S., Li, Y., Xu, H., Sun, Y., & Xu, S. (2022) · Results in Engineering · doi:10.1016/j.rineng.2022.100747 · Cited by 11 · see citing works
Glutamic acid-based dendritic peptides for scaffold-free cartilage tissue engineering
Sivadas, V. P., Dhawan, S., Babu, J., Haridas, V., & Nair, P. D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.010 · Cited by 11 · see citing works
Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin‐1
Mota, F., Yelland, T., Hutton, J. A., Parker, J., Patsiarika, A., Chan, A. W. E., O'Leary, A. P., Fotinou, C., Martin, J. F., Zachary, I. C., et al. (2021) · ChemBioChem · doi:10.1002/cbic.202100463 · Cited by 10 · see citing works
Kesharwani, K., Singh, R. S., Tripathi, S. K., Kaul, G., Akhir, A., Saxena, D., Kumar, V., Mishra, N. K., Chopra, S., & Joshi, K. B. (2022) · ChemistrySelect · doi:10.1002/slct.202202234 · Cited by 9 · see citing works
Wolff, M., Schüler, A., Gast, K., Seckler, R., Evers, A., Pfeiffer‐Marek, S., Kurz, M. E., Nagel, N., Haack, T., Wagner, M., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01195 · Cited by 8 · see citing works
Panda, C., Kumar, S., Gupta, S. K., & Pandey, L. M. (2024) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2024.2387167 · Cited by 8 · see citing works
Peptides for therapeutic applications – challenges and chances
Ruggirello, C., Mörl, K., & Beck‐Sickinger, A. G. (2024) · Pure and Applied Chemistry · doi:10.1515/pac-2024-0104 · Cited by 7 · see citing works
Huang, C., Wille, C. B., He, H., Reddy, V., Nargund, R. P., Lin, S., & Palani, A. (2017) · Tetrahedron Letters · doi:10.1016/j.tetlet.2017.02.031 · Cited by 7 · see citing works
Lipopeptides as Therapeutics: Applications and In Vivo Quantitative Analysis
Zemenová, J., Sýkora, D., Maletı́nská, L., & Kuneš, J. (2016) · Bioanalysis · doi:10.4155/bio-2016-0206 · Cited by 7 · see citing works
Design of stapled oxyntomodulin analogs containing functionalized biphenyl cross-linkers
Tian, Y., Zou, H., An, P., Zhou, Z., Shen, W., & Lin, Q. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.11.060 · Cited by 7 · see citing works
Biswas, K., Ilyas, H., Datta, A., & Bhunia, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190624090817 · Cited by 6 · see citing works
Giannetti, M., Palleschi, A., Ricciardi, B., & Venanzi, M. (2023) · Molecules · doi:10.3390/molecules28227536 · Cited by 5 · see citing works
Jiménez-Martí, E., Hurtado-Genovés, G., Aguilar-Ballester, M., Martínez‐Hervás, S., & Navarro, H. G. (2022) · Nutrients · doi:10.3390/nu14183775 · Cited by 5 · see citing works
A Survey and Guide to the Development of Fatty Acid‐derivatized Peptide Therapeutics
Jacobsen, M. T., Poulsen, C., Kopp, K. L., Olsen, J., & Cox, N. (2025) · Peptide Science · doi:10.1002/9781119824701.ch07 · Cited by 5 · see citing works
Yu, M., Zhang, C., Xu, H., Dong, Y., Zhu, H., Xia, C., & Feng, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-94014-0 · Cited by 4 · see citing works
Cyclic Peptides in Modern Drug Discovery: Trends and Therapeutic Directions
Thite, T., Iyer, K. A., Jain, P., Sasso, J. M., Tenchov, R., Murmu, S., Surendranath, M., Maind, A., Balande, U., & Zhou, Q. A. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01522 · Cited by 4 · see citing works
Makowska, M., Prahl, A., & Małuch, I. (2019) · Postępy Biochemii · doi:10.18388/pb.2019_280 · Cited by 4 · see citing works
Discovery of a Long-Acting Parathyroid Hormone 1–34 Analogue to Treat Hypoparathyroidism
Ruan, S., Gui-ying, Y., Dong, Y., Shangguan, W., & Lu, W. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00149 · Cited by 4 · see citing works
Méndez, L. R., Rodríguez-Cornejo, T., Rodríguez‐Ramos, T., Al-Hussinee, L., Velázquez, J., Campbell, J. H., Carpio, Y., Estrada, M. P., & Dixon, B. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109512 · Cited by 3 · see citing works
Evolution of Peptide Biopharmaceuticals
Иванов, В. Т., & Deigin, V. I. (2023) · Биоорганическая химия · doi:10.31857/s0132342323030120 · Cited by 3 · see citing works
Xu, Y., & Kuipers, O. P. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00132 · Cited by 3 · see citing works
Prabhu, A., Pise, N., Raheja, R., & Dhala, I. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220908150054 · Cited by 3 · see citing works
Strnadová, V., Morgan, A., Škrlová, M., Haasová, E., Bardová, K., Myšková, A., Sýkora, D., Kuneš, J., Železná, B., & Maletı́nská, L. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102417 · Cited by 3 · see citing works
Max Bergmann award lecture:Macromolecular medicinal chemistry as applied to metabolic diseases
DiMarchi, R. D., Mayer, J. P., Gelfanov, V. M., & Tschöp, M. H. (2018) · Journal of Peptide Science · doi:10.1002/psc.3056 · Cited by 2 · see citing works
Self-citationEvolution of Peptide Drug Biopharmaceutics
Иванов, В. Т., & Deigin, V. I. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023030123 · Cited by 2 · see citing works
Singh, S. S., Calvo, R., Kumari, A., Sable, R. V., Fang, Y., Tao, D., Hu, X., Castle, S. G., Nahar, S., Li, D., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0790 · Cited by 2 · see citing works
Lipidation Effect on Surface Adsorption and Associated Fibrillation of the Model Protein Insulin
Hedegaard, S. F., Cárdenas, M., Barker, R. D., Jørgensen, L., & van de Weert, M. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b00522 · Cited by 2 · see citing works
Poupart, J., Hou, X., Chemtob, S., & Lubell, W. D. (2019) · Molecules · doi:10.3390/molecules24224141 · Cited by 2 · see citing works
Santoro, A., Macis, M., D’Ursi, A. M., & Ricci, A. (2026) · Molecules · doi:10.3390/molecules31152556 · Cited by 1 · see citing works
He, R., Mowery, S. A., Chabenne, J. R., Finan, B., Mayer, J. P., & DiMarchi, R. D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.693958 · Cited by 1 · see citing works
Self-citationMolecular Imaging Agent Design for Quantifying Beta Cell Mass in Type 1 Diabetes
Zhang, L. (2017) · Deep Blue (University of Michigan)
Atangcho, L. (2020) · Deep Blue (University of Michigan)
Chemistry and sources of protein
Kumar, V., Ragaza, J. A., & Glencross, B. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90873-3.00017-8
Incorporation of D-amino Acids and Ornithines into Tirzepatide by Biosynthesis in E. Coli
Xu, Y., Fu, Y., & Kuipers, O. P. (2026) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-026-10813-7
Chemical dialogues at the peanut root microbiome interface orchestrate microbial signaling networks
Gelaye, Y. (2026) · Discover Agriculture · doi:10.1007/s44279-026-00584-6
Lipidated peptides and the limits of chemical control
Roque‐Borda, C. A., Sharma, A., Pavan, F. R., de la Torre, B. G., & Alberício, F. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1807712
- Authors
- Ward, B. P., Ottaway, N. L., Perez-Tilve, D., Ma, D., Gelfanov, V. M., Tschöp, M. H., & DiMarchi, R. D.
- Affiliations
- Indiana University Bloomington (US)
- University of Cincinnati (US)
- Helmholtz Munich (DE)
- Corresponding author
- Ward, Brian P.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 2
- Issue
- 4
- Pages
- 468-479
- ISSN
- 2212-8778 (ISSN-L)
- PMC
- PMC3854995
- OpenAlex
- W2047944726
- Cited by
- 101
- References
- 43
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 6 · 2014: 4
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Metabolism (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Keywords
- glucagon receptor, GLP-1 receptor, weight loss, blood glucose reduction, obesity, diabetes mellitus, prediabetes, intramolecular interactions, post-translational modification, structure-activity relationship
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review